UCLouvain
" We are designing bacteria that produces the essential protease of COVID-19 and whose activity is associated with sensitivity to a specific antibiotics. This bacteria is a powerful platform for screening potential inhibitors of the protease (the bacteria becomes resistant to the antibiotics if the protease is inhibited). We will use it to screen large combinatorial libraires of cyclic peptides that will be produced by the bacteria as well. "
Funding: Lab funds. FRNS grant application ongoing.
Contact: Patrice Soumillion Louvain Institute of Biomolecular Science and Technology, UCLouvain Place Croix du Sud 4-5 1348 Louvain-la-Neuve